Researchers from IDIBAPS, IBEC, UB and CIBERES discover how force dynamics affect cells and living tissues. The results give an insight into the cr...
It has a budget of 21 million euros and will have a duration of 5 years
Researchers from the group Mitochondrial regulation of cell death and steatohepatitis have revealed a new role for acid ceramidase (ACDase) in expe...
Researchers from Hospital Clínic-IDIBAPS have shown for the first time that the benefit of chemotherapy in premenopausal patients with low-risk hor...
A study published in the journal Molecular Psychiatry, which is part of the Nature group, has conducted a meta-analysis with data from 192 epidemio...
A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive t...
IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver...
For the first time it has been confirmed that some patients with autoimmune encephalitis of unknown origin produce autoantibodies against a subunit...
The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 2...
Artigas is the head of the IDIBAPS-IIBB-CSIC research group Systems Neuropharmacology, which works to find out the alterations of the neuronal circ...
